Home » Topics » Regulatory » Patents

Patents
RSS

ADIR claims 2-aminoindanes for CNS disorders involving serotonergic system dysfunction

Oct. 2, 1998

Progesterone antagonists claimed for cancer, gynecological disorders by Meiji Seika

Oct. 1, 1998

Agents for dementia a focus of R&D at Sanofi

Oct. 1, 1998

Peptides that bind to MHC class II proteins in development at Zeneca

Oct. 1, 1998

Selectin inhibitors described by Sanwa Kagaku for inflammatory disorders

Oct. 1, 1998

Neurogen compounds interacting with CRF1 receptors for stress-related disorders

Oct. 1, 1998

BASF patents new series with endothelin-antagonist activity

Oct. 1, 1998

Novel erythromycins from HMR useful for Gram-positive and other infections

Oct. 1, 1998

Piperazines as inhibitors of MMPs and/or TNF-alpha prepared at Fujisawa

Oct. 1, 1998

Yamanouchi and Merck KGaA work together to develop Na+/H+ exchange inhibitors

Sep. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...